JPRN-jRCT2011210044招募中1 期
A Phase 1 study of TAS-116 (pimitespib) in combination with imatinib in patients with advanced gastrointestinal stromal tumor (GIST) - CHAPTER-GIST-101
适应症
试验速览
- 阶段
- 1 期
- 状态
- 招募中
- 发起方
- Sato Atsushi
- 入组人数
- 78
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 18age old 至 ot applicable（—）
- 性别
- All
入选标准
- •Provided written informed consent
- •- Histologically confirmed GIST
- •- Progressed on the basis of imaging during or within 6 months of the last imatinib administration at enrollment
- •- Eastern Cooperative Oncology Group (ECOG) performance status of 0 to 1
排除标准
- •- Received treatment with any other line of therapy besides imatinib for advanced GIST; including local surgery and radiotherapy
- •- A serious illness or medical condition
- •- Previous or concurrent cancer that is distinct in primary disease or histology from cancer that is being evaluated in this study
- •- Pregnancy or lactation (including lactation interruption)
研究者
相似试验
进行中（未招募）
1 期
A Study of Pimitespib in Combination With Imatinib in Patients With GIST (CHAPTER-GIST-101)Gastrointestinal Stromal TumorsNCT05245968Taiho Pharmaceutical Co., Ltd.78
已完成
1 期
Phase I study of TAS-116 in combination with Nivolumab in patients with progressive or metastatic solid cancer[Dose escalation cohort] Progressive or metastatic solid tumors (regardless of cancer types) [Expansion cohort] Advanced or metastatic solid tumors (stomach cancer, lung cancer, pancreatic cancer, biliary tract cancer, etc.)JPRN-UMIN000032801ational Cancer Center Hospital East48
已完成
1 期
Phase I/II study of TAS-117 in combination with TAS-120Advanced solid tumorsJPRN-jRCT2080224785Taiho Pharmaceutical Co., Ltd.137
招募中
1 期
TAS-116 Plus Palbociclib in Breast and Rb-null CancerTreatment-Refractory Solid TumorsRetinoblastoma DeficiencySoft Tissue SarcomaEndometrial CancerBladder CancerAdvanced Breast CancerSCLCNCT05655598Brown University27
已完成
1 期
A phase I/II trial of TAS-102 in combination with irinotecan in Japanese patients with advanced gastric cancer refractory to standard chemotherapiesadvanced gastric cancer refractory to standard chemotherapiesJPRN-UMIN000031346St. Marianna University School of Medicine11